Royal Bank of Canada’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-959
Closed 7264
2023
Q2
$0 Buy
959
+61
+7% ﹤0.01% 7310
2023
Q1
$0 Sell
898
-43
-5% ﹤0.01% 7111
2022
Q4
$0 Buy
941
+36
+4% ﹤0.01% 7405
2022
Q3
$1K Sell
905
-238
-21% -$263 ﹤0.01% 6853
2022
Q2
$0 Sell
1,143
-4,235
-79% ﹤0.01% 7346
2022
Q1
$6K Sell
5,378
-14,306
-73% -$16K ﹤0.01% 6732
2021
Q4
$45K Buy
19,684
+9,826
+100% +$22.5K ﹤0.01% 5905
2021
Q3
$34K Buy
9,858
+3,798
+63% +$13.1K ﹤0.01% 5867
2021
Q2
$18K Sell
6,060
-7,995
-57% -$23.7K ﹤0.01% 6125
2021
Q1
$45K Buy
14,055
+13,820
+5,881% +$44.2K ﹤0.01% 5468
2020
Q4
$0 Sell
235
-766
-77% ﹤0.01% 6745
2020
Q3
$1K Sell
1,001
-200
-17% -$200 ﹤0.01% 6018
2020
Q2
$1K Buy
1,201
+163
+16% +$136 ﹤0.01% 6040
2020
Q1
$1K Buy
1,038
+347
+50% +$334 ﹤0.01% 6028
2019
Q4
$0 Sell
691
-105
-13% ﹤0.01% 6422
2019
Q3
$1K Buy
796
+596
+298% +$749 ﹤0.01% 5872
2019
Q2
$0 Hold
200
﹤0.01% 6090
2019
Q1
$0 Hold
200
﹤0.01% 6005
2018
Q4
$0 Sell
200
-114
-36% ﹤0.01% 6240
2018
Q3
$1K Sell
314
-386
-55% -$1.23K ﹤0.01% 6020
2018
Q2
$1K Buy
+700
New +$1K ﹤0.01% 5828
2018
Q1
Sell
-227
Closed 6082
2017
Q4
$0 Sell
227
-1,273
-85% ﹤0.01% 6132
2017
Q3
$2K Hold
1,500
﹤0.01% 5809
2017
Q2
$2K Sell
1,500
-2,121
-59% -$2.83K ﹤0.01% 5551
2017
Q1
$11K Sell
3,621
-1,197
-25% -$3.64K ﹤0.01% 5254
2016
Q4
$6K Buy
4,818
+3,202
+198% +$3.99K ﹤0.01% 5490
2016
Q3
$2K Hold
1,616
﹤0.01% 5443
2016
Q2
$2K Buy
+1,616
New +$2K ﹤0.01% 5450
2015
Q3
Sell
-19,418
Closed -$212K 6157
2015
Q2
$212K Buy
19,418
+13,918
+253% +$152K ﹤0.01% 3846
2015
Q1
$77K Sell
5,500
-35,067
-86% -$491K ﹤0.01% 4298
2014
Q4
$685K Buy
40,567
+3,000
+8% +$50.7K ﹤0.01% 2758
2014
Q3
$504K Sell
37,567
-400
-1% -$5.37K ﹤0.01% 2964
2014
Q2
$483K Buy
37,967
+32,017
+538% +$407K ﹤0.01% 2984
2014
Q1
$71K Buy
5,950
+700
+13% +$8.35K ﹤0.01% 4188
2013
Q4
$73K Buy
5,250
+2,588
+97% +$36K ﹤0.01% 4132
2013
Q3
$46K Sell
2,662
-3,155
-54% -$54.5K ﹤0.01% 4293
2013
Q2
$94K Buy
+5,817
New +$94K ﹤0.01% 3773